Clinical outcomes of the sequential use of pazopanib followed by everolimus for the treatment of metastatic renal cell carcinoma: A multicentre study in Korea.

Kim, Jeong Ho; Lee, Wan; Kim, Tae Nam; Nam, Jong Kil; Kim, Tae Hyo; Lee, Ki Soo

Kim, Jeong Ho; Lee, Wan; Kim, Tae Nam; Nam, Jong Kil; Kim, Tae Hyo; Lee, Ki Soo.

Afiliação

Kim JH; Dongnam Institute of Radiological & Medical Sciences Cancer Centre, Korea.
Lee W; Dongnam Institute of Radiological & Medical Sciences Cancer Centre, Korea.
Kim TN; Department of Urology, Pusan National University Hospital, Busan, Korea.
Nam JK; Department of Urology, Pusan National University Hospital, Busan, Korea.
Kim TH; Department of Urology, Dong-A University Hospital, Busan; Korea.
Lee KS; Department of Urology, Dong-A University Hospital, Busan; Korea.

Can Urol Assoc J ; 12(1): E15-E20, 2018 Jan.

Article em En | MEDLINE | ID: mdl-29173270

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 3_ND Problema de saúde: 3_diarrhea Tipo de estudo: Prognostic_studies Idioma: En Revista: Can Urol Assoc J Ano de publicação: 2018 Tipo de documento: Article

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google